Advance Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$227K Sell
2,214
-21
-0.9% -$2.37K 0.01% 157
2025
Q4
$280K Hold
2,235
0.01% 139
2025
Q3
$299K Buy
2,235
+16
+0.7% +$2.1K 0.01% 135
2025
Q2
$302K Sell
2,219
-3
-0.1% -$396 0.01% 128
2025
Q1
$295K Sell
2,222
-50
-2% -$6.36K 0.01% 119
2024
Q4
$257K Buy
2,272
+42
+2% +$4.85K 0.01% 129
2024
Q3
$254K Sell
2,230
-180
-7% -$19.7K 0.01% 129
2024
Q2
$250K Sell
2,410
-24
-1% -$2.54K 0.01% 131
2024
Q1
$277K Buy
2,434
+115
+5% +$13.2K 0.02% 118
2023
Q4
$255K Buy
2,319
+120
+5% +$12K 0.02% 110
2023
Q3
$213K Buy
2,199
+72
+3% +$7.56K 0.02% 119
2023
Q2
$232K Buy
+2,127
New +$227K 0.03% 110

Other funds holding ABT

Advance Capital Management's ABT Position: Q1 2026 in Review

Advance Capital Management reduced its Abbott (ABT) stake by 0.94% in Q1 2026, selling an estimated $2.37K and leaving 2,214 shares worth $227K. The position accounts for 0.01% of the portfolio, ranked #157.

Advance Capital Management first reported a position in ABT in Q2 2023 and has held it in 12 quarters since. The position peaked at $302K in Q2 2025. 3,090 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Advance Capital Management held 2,214 shares of Abbott worth $227K as of Q1 2026.
  • Advance Capital Management sold 21 Abbott shares in Q1 2026, an estimated $2.37K.
  • Abbott made up 0.01% of Advance Capital Management's portfolio in Q1 2026, its #157 holding.
  • Advance Capital Management first reported a position in Abbott in Q2 2023 and has held it in 12 quarters since.
  • Advance Capital Management's Abbott position peaked at $302K in Q2 2025.
  • 3,090 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Advance Capital Management's 13F filing for Q1 2026, filed 29 Apr 2026.